nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—stomach cancer	0.239	1	CbGaD
Norethindrone—ABCB1—Mitomycin—stomach cancer	0.0909	0.173	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0478	0.0907	CbGbCtD
Norethindrone—CYP3A7—Irinotecan—stomach cancer	0.0478	0.0907	CbGbCtD
Norethindrone—ALB—Irinotecan—stomach cancer	0.0446	0.0846	CbGbCtD
Norethindrone—ALB—Fluorouracil—stomach cancer	0.0428	0.0812	CbGbCtD
Norethindrone—CYP3A5—Irinotecan—stomach cancer	0.0358	0.068	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.035	0.0664	CbGbCtD
Norethindrone—CYP3A7—Docetaxel—stomach cancer	0.035	0.0664	CbGbCtD
Norethindrone—CYP3A5—Docetaxel—stomach cancer	0.0263	0.0498	CbGbCtD
Norethindrone—ALB—Methotrexate—stomach cancer	0.0236	0.0448	CbGbCtD
Norethindrone—ABCB1—Irinotecan—stomach cancer	0.0233	0.0443	CbGbCtD
Norethindrone—ABCB1—Docetaxel—stomach cancer	0.0171	0.0324	CbGbCtD
Norethindrone—CYP3A4—Irinotecan—stomach cancer	0.014	0.0265	CbGbCtD
Norethindrone—ABCB1—Doxorubicin—stomach cancer	0.0127	0.0242	CbGbCtD
Norethindrone—ABCB1—Methotrexate—stomach cancer	0.0123	0.0234	CbGbCtD
Norethindrone—CYP3A4—Docetaxel—stomach cancer	0.0102	0.0194	CbGbCtD
Norethindrone—CYP3A4—Doxorubicin—stomach cancer	0.00763	0.0145	CbGbCtD
Norethindrone—PGR—blood vessel—stomach cancer	0.00224	0.0844	CbGeAlD
Norethindrone—ALB—gall bladder—stomach cancer	0.00193	0.0728	CbGeAlD
Norethindrone—SHBG—hematopoietic system—stomach cancer	0.00133	0.0499	CbGeAlD
Norethindrone—PGR—hematopoietic system—stomach cancer	0.00119	0.0449	CbGeAlD
Norethindrone—CYP3A7—endocrine gland—stomach cancer	0.00113	0.0427	CbGeAlD
Norethindrone—PGR—epithelium—stomach cancer	0.00109	0.0411	CbGeAlD
Norethindrone—PGR—smooth muscle tissue—stomach cancer	0.00105	0.0396	CbGeAlD
Norethindrone—CYP3A7—liver—stomach cancer	0.00102	0.0385	CbGeAlD
Norethindrone—CYP2C19—hematopoietic system—stomach cancer	0.000881	0.0332	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—liver—stomach cancer	0.000869	0.0327	CbGeAlD
Norethindrone—SHBG—bone marrow—stomach cancer	0.00085	0.032	CbGeAlD
Norethindrone—PGR—lymphoid tissue—stomach cancer	0.000841	0.0316	CbGeAlD
Norethindrone—SHBG—endocrine gland—stomach cancer	0.000762	0.0287	CbGeAlD
Norethindrone—CYP3A5—hematopoietic system—stomach cancer	0.000694	0.0261	CbGeAlD
Norethindrone—ABCB1—blood vessel—stomach cancer	0.000693	0.0261	CbGeAlD
Norethindrone—SHBG—liver—stomach cancer	0.000687	0.0258	CbGeAlD
Norethindrone—PGR—endocrine gland—stomach cancer	0.000686	0.0258	CbGeAlD
Norethindrone—CYP2C19—digestive system—stomach cancer	0.000613	0.0231	CbGeAlD
Norethindrone—ALB—liver—stomach cancer	0.000567	0.0213	CbGeAlD
Norethindrone—CYP3A5—pancreas—stomach cancer	0.000565	0.0213	CbGeAlD
Norethindrone—Hydrocortisone—ANXA1—stomach cancer	0.000552	0.56	CrCbGaD
Norethindrone—CYP3A4—hematopoietic system—stomach cancer	0.000521	0.0196	CbGeAlD
Norethindrone—CYP2C19—endocrine gland—stomach cancer	0.000506	0.0191	CbGeAlD
Norethindrone—CYP3A5—digestive system—stomach cancer	0.000483	0.0182	CbGeAlD
Norethindrone—PGR—lymph node—stomach cancer	0.000474	0.0178	CbGeAlD
Norethindrone—CYP2C19—liver—stomach cancer	0.000457	0.0172	CbGeAlD
Norethindrone—ALB—lymph node—stomach cancer	0.000435	0.0164	CbGeAlD
Norethindrone—Haemorrhage—Fluorouracil—stomach cancer	0.000428	0.00256	CcSEcCtD
Norethindrone—Migraine—Capecitabine—stomach cancer	0.000426	0.00254	CcSEcCtD
Norethindrone—Pulmonary embolism—Epirubicin—stomach cancer	0.000415	0.00248	CcSEcCtD
Norethindrone—Mood swings—Capecitabine—stomach cancer	0.00041	0.00245	CcSEcCtD
Norethindrone—Immune system disorder—Irinotecan—stomach cancer	0.000404	0.00241	CcSEcCtD
Norethindrone—Breast disorder—Docetaxel—stomach cancer	0.000404	0.00241	CcSEcCtD
Norethindrone—CYP3A5—endocrine gland—stomach cancer	0.000399	0.015	CbGeAlD
Norethindrone—Alopecia—Irinotecan—stomach cancer	0.000395	0.00236	CcSEcCtD
Norethindrone—Breast disorder—Capecitabine—stomach cancer	0.000391	0.00233	CcSEcCtD
Norethindrone—Pulmonary embolism—Doxorubicin—stomach cancer	0.000384	0.00229	CcSEcCtD
Norethindrone—Flatulence—Irinotecan—stomach cancer	0.000384	0.00229	CcSEcCtD
Norethindrone—Alopecia—Fluorouracil—stomach cancer	0.000379	0.00226	CcSEcCtD
Norethindrone—Abdominal distension—Capecitabine—stomach cancer	0.000377	0.00225	CcSEcCtD
Norethindrone—Thrombophlebitis—Methotrexate—stomach cancer	0.000372	0.00222	CcSEcCtD
Norethindrone—ABCB1—hematopoietic system—stomach cancer	0.000369	0.0139	CbGeAlD
Norethindrone—Photosensitivity—Methotrexate—stomach cancer	0.000367	0.00219	CcSEcCtD
Norethindrone—CYP3A4—digestive system—stomach cancer	0.000362	0.0136	CbGeAlD
Norethindrone—CYP3A5—liver—stomach cancer	0.00036	0.0135	CbGeAlD
Norethindrone—Weight increased—Docetaxel—stomach cancer	0.000352	0.0021	CcSEcCtD
Norethindrone—Thrombophlebitis—Epirubicin—stomach cancer	0.000348	0.00208	CcSEcCtD
Norethindrone—Photosensitivity—Epirubicin—stomach cancer	0.000343	0.00205	CcSEcCtD
Norethindrone—Photosensitivity reaction—Capecitabine—stomach cancer	0.000341	0.00204	CcSEcCtD
Norethindrone—Weight increased—Capecitabine—stomach cancer	0.00034	0.00203	CcSEcCtD
Norethindrone—Acute coronary syndrome—Docetaxel—stomach cancer	0.00034	0.00203	CcSEcCtD
Norethindrone—Renal failure—Docetaxel—stomach cancer	0.000339	0.00202	CcSEcCtD
Norethindrone—Myocardial infarction—Docetaxel—stomach cancer	0.000338	0.00201	CcSEcCtD
Norethindrone—ABCB1—epithelium—stomach cancer	0.000337	0.0127	CbGeAlD
Norethindrone—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000333	0.00199	CcSEcCtD
Norethindrone—Depression—Capecitabine—stomach cancer	0.000333	0.00198	CcSEcCtD
Norethindrone—Acute coronary syndrome—Capecitabine—stomach cancer	0.000329	0.00196	CcSEcCtD
Norethindrone—Renal failure—Capecitabine—stomach cancer	0.000328	0.00196	CcSEcCtD
Norethindrone—Myocardial infarction—Capecitabine—stomach cancer	0.000327	0.00195	CcSEcCtD
Norethindrone—Hepatobiliary disease—Docetaxel—stomach cancer	0.000326	0.00194	CcSEcCtD
Norethindrone—Convulsion—Fluorouracil—stomach cancer	0.000323	0.00193	CcSEcCtD
Norethindrone—Thrombophlebitis—Doxorubicin—stomach cancer	0.000322	0.00192	CcSEcCtD
Norethindrone—Oedema—Irinotecan—stomach cancer	0.000318	0.0019	CcSEcCtD
Norethindrone—Anaphylactic shock—Irinotecan—stomach cancer	0.000318	0.0019	CcSEcCtD
Norethindrone—Photosensitivity—Doxorubicin—stomach cancer	0.000318	0.0019	CcSEcCtD
Norethindrone—Renal impairment—Epirubicin—stomach cancer	0.000317	0.00189	CcSEcCtD
Norethindrone—Hepatobiliary disease—Capecitabine—stomach cancer	0.000315	0.00188	CcSEcCtD
Norethindrone—Purpura—Epirubicin—stomach cancer	0.000313	0.00187	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000312	0.00186	CcSEcCtD
Norethindrone—Haemoglobin—Docetaxel—stomach cancer	0.000311	0.00185	CcSEcCtD
Norethindrone—Hepatitis—Docetaxel—stomach cancer	0.000309	0.00185	CcSEcCtD
Norethindrone—Haemorrhage—Docetaxel—stomach cancer	0.000309	0.00185	CcSEcCtD
Norethindrone—Mood swings—Methotrexate—stomach cancer	0.000305	0.00182	CcSEcCtD
Norethindrone—Anaphylactic shock—Fluorouracil—stomach cancer	0.000304	0.00182	CcSEcCtD
Norethindrone—Oedema—Fluorouracil—stomach cancer	0.000304	0.00182	CcSEcCtD
Norethindrone—Connective tissue disorder—Docetaxel—stomach cancer	0.000304	0.00181	CcSEcCtD
Norethindrone—Pain in extremity—Epirubicin—stomach cancer	0.000302	0.0018	CcSEcCtD
Norethindrone—Haemoglobin—Capecitabine—stomach cancer	0.000301	0.0018	CcSEcCtD
Norethindrone—ABCB1—pancreas—stomach cancer	0.0003	0.0113	CbGeAlD
Norethindrone—Hepatitis—Capecitabine—stomach cancer	0.000299	0.00179	CcSEcCtD
Norethindrone—Haemorrhage—Capecitabine—stomach cancer	0.000299	0.00179	CcSEcCtD
Norethindrone—CYP3A4—endocrine gland—stomach cancer	0.000299	0.0113	CbGeAlD
Norethindrone—Migraine—Epirubicin—stomach cancer	0.000297	0.00177	CcSEcCtD
Norethindrone—Affect lability—Epirubicin—stomach cancer	0.000297	0.00177	CcSEcCtD
Norethindrone—Connective tissue disorder—Capecitabine—stomach cancer	0.000294	0.00176	CcSEcCtD
Norethindrone—Renal impairment—Doxorubicin—stomach cancer	0.000293	0.00175	CcSEcCtD
Norethindrone—Erythema multiforme—Docetaxel—stomach cancer	0.000292	0.00174	CcSEcCtD
Norethindrone—Breast disorder—Methotrexate—stomach cancer	0.000291	0.00174	CcSEcCtD
Norethindrone—Purpura—Doxorubicin—stomach cancer	0.000289	0.00173	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000288	0.00172	CcSEcCtD
Norethindrone—Insomnia—Irinotecan—stomach cancer	0.000287	0.00172	CcSEcCtD
Norethindrone—Mood swings—Epirubicin—stomach cancer	0.000286	0.0017	CcSEcCtD
Norethindrone—Erythema multiforme—Capecitabine—stomach cancer	0.000283	0.00169	CcSEcCtD
Norethindrone—Somnolence—Irinotecan—stomach cancer	0.000283	0.00169	CcSEcCtD
Norethindrone—Dyspepsia—Irinotecan—stomach cancer	0.00028	0.00167	CcSEcCtD
Norethindrone—Immune system disorder—Docetaxel—stomach cancer	0.000279	0.00167	CcSEcCtD
Norethindrone—Pain in extremity—Doxorubicin—stomach cancer	0.000279	0.00166	CcSEcCtD
Norethindrone—Insomnia—Fluorouracil—stomach cancer	0.000275	0.00164	CcSEcCtD
Norethindrone—Migraine—Doxorubicin—stomach cancer	0.000275	0.00164	CcSEcCtD
Norethindrone—Affect lability—Doxorubicin—stomach cancer	0.000275	0.00164	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000274	0.00164	CcSEcCtD
Norethindrone—Fatigue—Irinotecan—stomach cancer	0.000274	0.00163	CcSEcCtD
Norethindrone—Alopecia—Docetaxel—stomach cancer	0.000273	0.00163	CcSEcCtD
Norethindrone—Breast disorder—Epirubicin—stomach cancer	0.000272	0.00163	CcSEcCtD
Norethindrone—Mental disorder—Docetaxel—stomach cancer	0.000271	0.00162	CcSEcCtD
Norethindrone—Somnolence—Fluorouracil—stomach cancer	0.000271	0.00161	CcSEcCtD
Norethindrone—Immune system disorder—Capecitabine—stomach cancer	0.00027	0.00161	CcSEcCtD
Norethindrone—CYP3A4—liver—stomach cancer	0.00027	0.0102	CbGeAlD
Norethindrone—Dyspepsia—Fluorouracil—stomach cancer	0.000268	0.0016	CcSEcCtD
Norethindrone—Alopecia—Capecitabine—stomach cancer	0.000265	0.00158	CcSEcCtD
Norethindrone—Mood swings—Doxorubicin—stomach cancer	0.000264	0.00158	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000263	0.00157	CcSEcCtD
Norethindrone—Abdominal distension—Epirubicin—stomach cancer	0.000262	0.00157	CcSEcCtD
Norethindrone—Mental disorder—Capecitabine—stomach cancer	0.000262	0.00157	CcSEcCtD
Norethindrone—Gastrointestinal pain—Irinotecan—stomach cancer	0.00026	0.00155	CcSEcCtD
Norethindrone—ABCB1—lymphoid tissue—stomach cancer	0.00026	0.00977	CbGeAlD
Norethindrone—Flatulence—Capecitabine—stomach cancer	0.000257	0.00153	CcSEcCtD
Norethindrone—ABCB1—digestive system—stomach cancer	0.000257	0.00965	CbGeAlD
Norethindrone—Photosensitivity reaction—Methotrexate—stomach cancer	0.000254	0.00152	CcSEcCtD
Norethindrone—Breast disorder—Doxorubicin—stomach cancer	0.000252	0.0015	CcSEcCtD
Norethindrone—Abdominal pain—Irinotecan—stomach cancer	0.000251	0.0015	CcSEcCtD
Norethindrone—Drowsiness—Methotrexate—stomach cancer	0.000248	0.00148	CcSEcCtD
Norethindrone—Depression—Methotrexate—stomach cancer	0.000248	0.00148	CcSEcCtD
Norethindrone—Renal failure—Methotrexate—stomach cancer	0.000244	0.00146	CcSEcCtD
Norethindrone—Abdominal distension—Doxorubicin—stomach cancer	0.000243	0.00145	CcSEcCtD
Norethindrone—Urticaria—Fluorouracil—stomach cancer	0.000242	0.00144	CcSEcCtD
Norethindrone—Photosensitivity reaction—Epirubicin—stomach cancer	0.000238	0.00142	CcSEcCtD
Norethindrone—Weight increased—Epirubicin—stomach cancer	0.000237	0.00142	CcSEcCtD
Norethindrone—ABCB1—bone marrow—stomach cancer	0.000236	0.0089	CbGeAlD
Norethindrone—Hepatobiliary disease—Methotrexate—stomach cancer	0.000235	0.0014	CcSEcCtD
Norethindrone—Hypersensitivity—Irinotecan—stomach cancer	0.000234	0.0014	CcSEcCtD
Norethindrone—Convulsion—Docetaxel—stomach cancer	0.000233	0.00139	CcSEcCtD
Norethindrone—Drowsiness—Epirubicin—stomach cancer	0.000232	0.00139	CcSEcCtD
Norethindrone—Renal failure—Epirubicin—stomach cancer	0.000228	0.00136	CcSEcCtD
Norethindrone—Asthenia—Irinotecan—stomach cancer	0.000228	0.00136	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000228	0.00136	CcSEcCtD
Norethindrone—Hypersensitivity—Fluorouracil—stomach cancer	0.000224	0.00134	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—stomach cancer	0.000224	0.00134	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—stomach cancer	0.000223	0.00133	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—stomach cancer	0.000223	0.00133	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00022	0.00131	CcSEcCtD
Norethindrone—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00022	0.00131	CcSEcCtD
Norethindrone—Hepatobiliary disease—Epirubicin—stomach cancer	0.00022	0.00131	CcSEcCtD
Norethindrone—Anaphylactic shock—Docetaxel—stomach cancer	0.00022	0.00131	CcSEcCtD
Norethindrone—Oedema—Docetaxel—stomach cancer	0.00022	0.00131	CcSEcCtD
Norethindrone—Weight increased—Doxorubicin—stomach cancer	0.000219	0.00131	CcSEcCtD
Norethindrone—Pruritus—Fluorouracil—stomach cancer	0.000215	0.00129	CcSEcCtD
Norethindrone—Drowsiness—Doxorubicin—stomach cancer	0.000215	0.00128	CcSEcCtD
Norethindrone—Skin disorder—Docetaxel—stomach cancer	0.000213	0.00127	CcSEcCtD
Norethindrone—Oedema—Capecitabine—stomach cancer	0.000213	0.00127	CcSEcCtD
Norethindrone—ABCB1—endocrine gland—stomach cancer	0.000212	0.00797	CbGeAlD
Norethindrone—Renal failure—Doxorubicin—stomach cancer	0.000211	0.00126	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—stomach cancer	0.000211	0.00126	CcSEcCtD
Norethindrone—Dizziness—Irinotecan—stomach cancer	0.00021	0.00125	CcSEcCtD
Norethindrone—Haemoglobin—Epirubicin—stomach cancer	0.00021	0.00125	CcSEcCtD
Norethindrone—Haemorrhage—Epirubicin—stomach cancer	0.000209	0.00124	CcSEcCtD
Norethindrone—Hepatitis—Epirubicin—stomach cancer	0.000209	0.00124	CcSEcCtD
Norethindrone—Skin disorder—Capecitabine—stomach cancer	0.000207	0.00123	CcSEcCtD
Norethindrone—Connective tissue disorder—Epirubicin—stomach cancer	0.000205	0.00122	CcSEcCtD
Norethindrone—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000203	0.00121	CcSEcCtD
Norethindrone—Vomiting—Irinotecan—stomach cancer	0.000202	0.00121	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—stomach cancer	0.000201	0.0012	CcSEcCtD
Norethindrone—Dizziness—Fluorouracil—stomach cancer	0.000201	0.0012	CcSEcCtD
Norethindrone—Rash—Irinotecan—stomach cancer	0.0002	0.0012	CcSEcCtD
Norethindrone—Dermatitis—Irinotecan—stomach cancer	0.0002	0.00119	CcSEcCtD
Norethindrone—Headache—Irinotecan—stomach cancer	0.000199	0.00119	CcSEcCtD
Norethindrone—Insomnia—Docetaxel—stomach cancer	0.000199	0.00119	CcSEcCtD
Norethindrone—Erythema multiforme—Epirubicin—stomach cancer	0.000197	0.00118	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—stomach cancer	0.000197	0.00118	CcSEcCtD
Norethindrone—Somnolence—Docetaxel—stomach cancer	0.000195	0.00117	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—stomach cancer	0.000195	0.00117	CcSEcCtD
Norethindrone—Haemoglobin—Doxorubicin—stomach cancer	0.000194	0.00116	CcSEcCtD
Norethindrone—Vomiting—Fluorouracil—stomach cancer	0.000194	0.00115	CcSEcCtD
Norethindrone—Dyspepsia—Docetaxel—stomach cancer	0.000193	0.00115	CcSEcCtD
Norethindrone—Hepatitis—Doxorubicin—stomach cancer	0.000193	0.00115	CcSEcCtD
Norethindrone—Haemorrhage—Doxorubicin—stomach cancer	0.000193	0.00115	CcSEcCtD
Norethindrone—Insomnia—Capecitabine—stomach cancer	0.000192	0.00115	CcSEcCtD
Norethindrone—Rash—Fluorouracil—stomach cancer	0.000192	0.00115	CcSEcCtD
Norethindrone—Dermatitis—Fluorouracil—stomach cancer	0.000192	0.00114	CcSEcCtD
Norethindrone—ABCB1—liver—stomach cancer	0.000191	0.00719	CbGeAlD
Norethindrone—Headache—Fluorouracil—stomach cancer	0.000191	0.00114	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00019	0.00113	CcSEcCtD
Norethindrone—Connective tissue disorder—Doxorubicin—stomach cancer	0.00019	0.00113	CcSEcCtD
Norethindrone—Fatigue—Docetaxel—stomach cancer	0.000189	0.00113	CcSEcCtD
Norethindrone—Nausea—Irinotecan—stomach cancer	0.000189	0.00113	CcSEcCtD
Norethindrone—Immune system disorder—Epirubicin—stomach cancer	0.000188	0.00112	CcSEcCtD
Norethindrone—Dyspepsia—Capecitabine—stomach cancer	0.000187	0.00112	CcSEcCtD
Norethindrone—Alopecia—Epirubicin—stomach cancer	0.000184	0.0011	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000184	0.0011	CcSEcCtD
Norethindrone—Fatigue—Capecitabine—stomach cancer	0.000183	0.00109	CcSEcCtD
Norethindrone—Mental disorder—Epirubicin—stomach cancer	0.000183	0.00109	CcSEcCtD
Norethindrone—Erythema multiforme—Doxorubicin—stomach cancer	0.000182	0.00109	CcSEcCtD
Norethindrone—Nausea—Fluorouracil—stomach cancer	0.000181	0.00108	CcSEcCtD
Norethindrone—Gastrointestinal pain—Docetaxel—stomach cancer	0.00018	0.00107	CcSEcCtD
Norethindrone—Flatulence—Epirubicin—stomach cancer	0.000179	0.00107	CcSEcCtD
Norethindrone—Tension—Epirubicin—stomach cancer	0.000178	0.00106	CcSEcCtD
Norethindrone—Nervousness—Epirubicin—stomach cancer	0.000176	0.00105	CcSEcCtD
Norethindrone—Immune system disorder—Doxorubicin—stomach cancer	0.000174	0.00104	CcSEcCtD
Norethindrone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000174	0.00104	CcSEcCtD
Norethindrone—Abdominal pain—Docetaxel—stomach cancer	0.000174	0.00104	CcSEcCtD
Norethindrone—Alopecia—Doxorubicin—stomach cancer	0.000171	0.00102	CcSEcCtD
Norethindrone—Mental disorder—Doxorubicin—stomach cancer	0.000169	0.00101	CcSEcCtD
Norethindrone—Urticaria—Capecitabine—stomach cancer	0.000169	0.00101	CcSEcCtD
Norethindrone—Abdominal pain—Capecitabine—stomach cancer	0.000168	0.001	CcSEcCtD
Norethindrone—Convulsion—Methotrexate—stomach cancer	0.000168	0.001	CcSEcCtD
Norethindrone—Flatulence—Doxorubicin—stomach cancer	0.000166	0.000988	CcSEcCtD
Norethindrone—Tension—Doxorubicin—stomach cancer	0.000165	0.000984	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000164	0.000979	CcSEcCtD
Norethindrone—Nervousness—Doxorubicin—stomach cancer	0.000163	0.000974	CcSEcCtD
Norethindrone—Hypersensitivity—Docetaxel—stomach cancer	0.000162	0.000966	CcSEcCtD
Norethindrone—Anaphylactic shock—Methotrexate—stomach cancer	0.000158	0.000945	CcSEcCtD
Norethindrone—Asthenia—Docetaxel—stomach cancer	0.000158	0.000941	CcSEcCtD
Norethindrone—Convulsion—Epirubicin—stomach cancer	0.000157	0.000939	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—stomach cancer	0.000157	0.159	CrCbGaD
Norethindrone—Hypersensitivity—Capecitabine—stomach cancer	0.000157	0.000935	CcSEcCtD
Norethindrone—Pruritus—Docetaxel—stomach cancer	0.000155	0.000927	CcSEcCtD
Norethindrone—Skin disorder—Methotrexate—stomach cancer	0.000154	0.000918	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000154	0.000916	CcSEcCtD
Norethindrone—Asthenia—Capecitabine—stomach cancer	0.000153	0.000911	CcSEcCtD
Norethindrone—Pruritus—Capecitabine—stomach cancer	0.000151	0.000898	CcSEcCtD
Norethindrone—Anaphylactic shock—Epirubicin—stomach cancer	0.000148	0.000884	CcSEcCtD
Norethindrone—Oedema—Epirubicin—stomach cancer	0.000148	0.000884	CcSEcCtD
Norethindrone—ABCB1—lymph node—stomach cancer	0.000147	0.00551	CbGeAlD
Norethindrone—Convulsion—Doxorubicin—stomach cancer	0.000146	0.000869	CcSEcCtD
Norethindrone—Dizziness—Docetaxel—stomach cancer	0.000145	0.000867	CcSEcCtD
Norethindrone—Skin disorder—Epirubicin—stomach cancer	0.000144	0.000859	CcSEcCtD
Norethindrone—Insomnia—Methotrexate—stomach cancer	0.000143	0.000855	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000142	0.000848	CcSEcCtD
Norethindrone—Somnolence—Methotrexate—stomach cancer	0.000141	0.00084	CcSEcCtD
Norethindrone—Dizziness—Capecitabine—stomach cancer	0.000141	0.000839	CcSEcCtD
Norethindrone—Vomiting—Docetaxel—stomach cancer	0.00014	0.000834	CcSEcCtD
Norethindrone—Dyspepsia—Methotrexate—stomach cancer	0.000139	0.000832	CcSEcCtD
Norethindrone—Rash—Docetaxel—stomach cancer	0.000139	0.000827	CcSEcCtD
Norethindrone—Dermatitis—Docetaxel—stomach cancer	0.000138	0.000826	CcSEcCtD
Norethindrone—Progesterone—CYP2A6—stomach cancer	0.000138	0.14	CrCbGaD
Norethindrone—Headache—Docetaxel—stomach cancer	0.000138	0.000821	CcSEcCtD
Norethindrone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000137	0.000818	CcSEcCtD
Norethindrone—Oedema—Doxorubicin—stomach cancer	0.000137	0.000818	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000137	0.000816	CcSEcCtD
Norethindrone—Fatigue—Methotrexate—stomach cancer	0.000137	0.000815	CcSEcCtD
Norethindrone—Vomiting—Capecitabine—stomach cancer	0.000135	0.000807	CcSEcCtD
Norethindrone—Rash—Capecitabine—stomach cancer	0.000134	0.0008	CcSEcCtD
Norethindrone—Insomnia—Epirubicin—stomach cancer	0.000134	0.0008	CcSEcCtD
Norethindrone—Dermatitis—Capecitabine—stomach cancer	0.000134	0.0008	CcSEcCtD
Norethindrone—Headache—Capecitabine—stomach cancer	0.000133	0.000795	CcSEcCtD
Norethindrone—Skin disorder—Doxorubicin—stomach cancer	0.000133	0.000795	CcSEcCtD
Norethindrone—Somnolence—Epirubicin—stomach cancer	0.000132	0.000786	CcSEcCtD
Norethindrone—Nausea—Docetaxel—stomach cancer	0.000131	0.000779	CcSEcCtD
Norethindrone—Dyspepsia—Epirubicin—stomach cancer	0.00013	0.000778	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000129	0.000773	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000128	0.000763	CcSEcCtD
Norethindrone—Fatigue—Epirubicin—stomach cancer	0.000128	0.000762	CcSEcCtD
Norethindrone—Nausea—Capecitabine—stomach cancer	0.000126	0.000754	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—stomach cancer	0.000126	0.000751	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—stomach cancer	0.000125	0.000747	CcSEcCtD
Norethindrone—Insomnia—Doxorubicin—stomach cancer	0.000124	0.00074	CcSEcCtD
Norethindrone—Somnolence—Doxorubicin—stomach cancer	0.000122	0.000727	CcSEcCtD
Norethindrone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000121	0.000723	CcSEcCtD
Norethindrone—Dyspepsia—Doxorubicin—stomach cancer	0.000121	0.00072	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000118	0.000706	CcSEcCtD
Norethindrone—Fatigue—Doxorubicin—stomach cancer	0.000118	0.000705	CcSEcCtD
Norethindrone—Urticaria—Epirubicin—stomach cancer	0.000118	0.000702	CcSEcCtD
Norethindrone—Abdominal pain—Epirubicin—stomach cancer	0.000117	0.000699	CcSEcCtD
Norethindrone—Hypersensitivity—Methotrexate—stomach cancer	0.000117	0.000696	CcSEcCtD
Norethindrone—Asthenia—Methotrexate—stomach cancer	0.000114	0.000678	CcSEcCtD
Norethindrone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000112	0.000669	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—stomach cancer	0.000112	0.000668	CcSEcCtD
Norethindrone—Hypersensitivity—Epirubicin—stomach cancer	0.000109	0.000651	CcSEcCtD
Norethindrone—Urticaria—Doxorubicin—stomach cancer	0.000109	0.00065	CcSEcCtD
Norethindrone—Abdominal pain—Doxorubicin—stomach cancer	0.000108	0.000647	CcSEcCtD
Norethindrone—Asthenia—Epirubicin—stomach cancer	0.000106	0.000634	CcSEcCtD
Norethindrone—Pruritus—Epirubicin—stomach cancer	0.000105	0.000626	CcSEcCtD
Norethindrone—Dizziness—Methotrexate—stomach cancer	0.000105	0.000625	CcSEcCtD
Norethindrone—Hypersensitivity—Doxorubicin—stomach cancer	0.000101	0.000603	CcSEcCtD
Norethindrone—Vomiting—Methotrexate—stomach cancer	0.000101	0.000601	CcSEcCtD
Norethindrone—Rash—Methotrexate—stomach cancer	9.98e-05	0.000596	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—stomach cancer	9.98e-05	0.000595	CcSEcCtD
Norethindrone—Headache—Methotrexate—stomach cancer	9.92e-05	0.000592	CcSEcCtD
Norethindrone—Asthenia—Doxorubicin—stomach cancer	9.84e-05	0.000587	CcSEcCtD
Norethindrone—Dizziness—Epirubicin—stomach cancer	9.8e-05	0.000585	CcSEcCtD
Norethindrone—Pruritus—Doxorubicin—stomach cancer	9.7e-05	0.000579	CcSEcCtD
Norethindrone—Vomiting—Epirubicin—stomach cancer	9.42e-05	0.000562	CcSEcCtD
Norethindrone—Nausea—Methotrexate—stomach cancer	9.41e-05	0.000561	CcSEcCtD
Norethindrone—Rash—Epirubicin—stomach cancer	9.34e-05	0.000558	CcSEcCtD
Norethindrone—Dermatitis—Epirubicin—stomach cancer	9.34e-05	0.000557	CcSEcCtD
Norethindrone—Headache—Epirubicin—stomach cancer	9.28e-05	0.000554	CcSEcCtD
Norethindrone—Dizziness—Doxorubicin—stomach cancer	9.07e-05	0.000541	CcSEcCtD
Norethindrone—Nausea—Epirubicin—stomach cancer	8.8e-05	0.000525	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—stomach cancer	8.78e-05	0.089	CrCbGaD
Norethindrone—Vomiting—Doxorubicin—stomach cancer	8.72e-05	0.00052	CcSEcCtD
Norethindrone—Rash—Doxorubicin—stomach cancer	8.65e-05	0.000516	CcSEcCtD
Norethindrone—Dermatitis—Doxorubicin—stomach cancer	8.64e-05	0.000515	CcSEcCtD
Norethindrone—Headache—Doxorubicin—stomach cancer	8.59e-05	0.000513	CcSEcCtD
Norethindrone—Nausea—Doxorubicin—stomach cancer	8.14e-05	0.000486	CcSEcCtD
Norethindrone—Testosterone—ALB—stomach cancer	5.09e-05	0.0517	CrCbGaD
Norethindrone—CYP2C19—Metabolism—PLCE1—stomach cancer	1.5e-05	0.000386	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.49e-05	0.000385	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PDHA1—stomach cancer	1.49e-05	0.000383	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ECHS1—stomach cancer	1.49e-05	0.000383	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ENO1—stomach cancer	1.47e-05	0.00038	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—SERPINE1—stomach cancer	1.46e-05	0.000377	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLCE1—stomach cancer	1.46e-05	0.000377	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.46e-05	0.000377	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.45e-05	0.000374	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FYN—stomach cancer	1.44e-05	0.000371	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—UMPS—stomach cancer	1.43e-05	0.00037	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.43e-05	0.000369	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.41e-05	0.000365	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALDOB—stomach cancer	1.41e-05	0.000363	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—UMPS—stomach cancer	1.4e-05	0.000361	CbGpPWpGaD
Norethindrone—ALB—Metabolism—FADS1—stomach cancer	1.4e-05	0.00036	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TYMP—stomach cancer	1.4e-05	0.00036	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.4e-05	0.00036	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.4e-05	0.00036	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGFR2—stomach cancer	1.35e-05	0.000349	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PDHA1—stomach cancer	1.33e-05	0.000344	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ECHS1—stomach cancer	1.33e-05	0.000344	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.33e-05	0.000342	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SREBF2—stomach cancer	1.31e-05	0.000337	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CD44—stomach cancer	1.31e-05	0.000337	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALOX5—stomach cancer	1.31e-05	0.000337	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.31e-05	0.000337	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ECHS1—stomach cancer	1.3e-05	0.000336	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PDHA1—stomach cancer	1.3e-05	0.000336	CbGpPWpGaD
Norethindrone—ALB—Metabolism—RORA—stomach cancer	1.29e-05	0.000333	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—DPYD—stomach cancer	1.29e-05	0.000332	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PLAU—stomach cancer	1.28e-05	0.000331	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CAV1—stomach cancer	1.25e-05	0.000324	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.25e-05	0.000323	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FADS1—stomach cancer	1.25e-05	0.000323	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TYMP—stomach cancer	1.25e-05	0.000323	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.25e-05	0.000323	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—APOA1—stomach cancer	1.25e-05	0.000323	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PGLS—stomach cancer	1.24e-05	0.000321	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—BLVRB—stomach cancer	1.24e-05	0.000321	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IRS2—stomach cancer	1.24e-05	0.000319	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.24e-05	0.000318	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TYMP—stomach cancer	1.22e-05	0.000316	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FADS1—stomach cancer	1.22e-05	0.000316	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ALDOB—stomach cancer	1.21e-05	0.000312	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.2e-05	0.00031	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CAV1—stomach cancer	1.2e-05	0.000309	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOA1—stomach cancer	1.2e-05	0.000309	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PRKCB—stomach cancer	1.19e-05	0.000308	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.19e-05	0.000308	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.19e-05	0.000306	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.18e-05	0.000303	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.18e-05	0.000303	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SREBF2—stomach cancer	1.17e-05	0.000303	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—RORA—stomach cancer	1.16e-05	0.000299	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SREBF2—stomach cancer	1.15e-05	0.000296	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PRKCB—stomach cancer	1.14e-05	0.000295	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.14e-05	0.000295	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.14e-05	0.000294	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6ST—stomach cancer	1.14e-05	0.000293	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTT1—stomach cancer	1.14e-05	0.000293	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—RORA—stomach cancer	1.13e-05	0.000292	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ALOX5—stomach cancer	1.13e-05	0.00029	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.12e-05	0.00029	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.12e-05	0.000289	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1.11e-05	0.000287	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.11e-05	0.000286	CbGpPWpGaD
Norethindrone—ALB—Metabolism—DPYD—stomach cancer	1.11e-05	0.000286	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.09e-05	0.000282	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APC—stomach cancer	1.09e-05	0.000282	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTP1—stomach cancer	1.09e-05	0.000281	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALDOB—stomach cancer	1.09e-05	0.00028	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.08e-05	0.000279	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMOX1—stomach cancer	1.08e-05	0.000277	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ENO1—stomach cancer	1.07e-05	0.000275	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDOB—stomach cancer	1.06e-05	0.000274	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CKB—stomach cancer	1.06e-05	0.000273	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA1—stomach cancer	1.06e-05	0.000273	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FBP1—stomach cancer	1.06e-05	0.000273	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.06e-05	0.000273	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.04e-05	0.000267	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.03e-05	0.000264	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.02e-05	0.000264	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.02e-05	0.000263	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6R—stomach cancer	1.02e-05	0.000262	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—TYMS—stomach cancer	1.01e-05	0.000261	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALOX5—stomach cancer	1.01e-05	0.000261	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1e-05	0.000259	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—stomach cancer	1e-05	0.000258	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLIN2—stomach cancer	9.95e-06	0.000257	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—DPYD—stomach cancer	9.95e-06	0.000256	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SERPINE1—stomach cancer	9.94e-06	0.000256	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALOX5—stomach cancer	9.87e-06	0.000254	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	9.87e-06	0.000254	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTT1—stomach cancer	9.8e-06	0.000253	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—DPYD—stomach cancer	9.71e-06	0.00025	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2A6—stomach cancer	9.68e-06	0.00025	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA2—stomach cancer	9.68e-06	0.00025	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—RHOA—stomach cancer	9.59e-06	0.000247	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MAPK3—stomach cancer	9.51e-06	0.000245	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SERPINE1—stomach cancer	9.51e-06	0.000245	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	9.5e-06	0.000245	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS3—stomach cancer	9.49e-06	0.000245	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD44—stomach cancer	9.45e-06	0.000244	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NT5E—stomach cancer	9.43e-06	0.000243	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PGAM1—stomach cancer	9.43e-06	0.000243	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ERCC2—stomach cancer	9.43e-06	0.000243	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKR1C3—stomach cancer	9.42e-06	0.000243	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—stomach cancer	9.25e-06	0.000239	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ENO1—stomach cancer	9.18e-06	0.000237	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RHOA—stomach cancer	9.17e-06	0.000236	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOS3—stomach cancer	9.08e-06	0.000234	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.02e-06	0.000232	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLCE1—stomach cancer	9e-06	0.000232	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDH7A1—stomach cancer	9e-06	0.000232	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—stomach cancer	8.86e-06	0.000228	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTT1—stomach cancer	8.8e-06	0.000227	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2A6—stomach cancer	8.69e-06	0.000224	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UMPS—stomach cancer	8.63e-06	0.000222	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTT1—stomach cancer	8.58e-06	0.000221	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ERBB2—stomach cancer	8.49e-06	0.000219	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2A6—stomach cancer	8.49e-06	0.000219	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKR1C3—stomach cancer	8.46e-06	0.000218	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKR1C3—stomach cancer	8.25e-06	0.000213	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ENO1—stomach cancer	8.24e-06	0.000212	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CAV1—stomach cancer	8.17e-06	0.000211	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOA1—stomach cancer	8.15e-06	0.00021	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD44—stomach cancer	8.14e-06	0.00021	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.11e-06	0.000209	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL8—stomach cancer	8.05e-06	0.000208	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ENO1—stomach cancer	8.04e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPP2R1A—stomach cancer	8.04e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PDHA1—stomach cancer	8.02e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ECHS1—stomach cancer	8.02e-06	0.000207	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.9e-06	0.000204	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—stomach cancer	7.89e-06	0.000203	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—stomach cancer	7.86e-06	0.000203	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—stomach cancer	7.78e-06	0.000201	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FADS1—stomach cancer	7.54e-06	0.000194	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TYMP—stomach cancer	7.54e-06	0.000194	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	7.52e-06	0.000194	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—stomach cancer	7.5e-06	0.000193	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—stomach cancer	7.48e-06	0.000193	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TYMS—stomach cancer	7.33e-06	0.000189	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD44—stomach cancer	7.31e-06	0.000188	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—stomach cancer	7.28e-06	0.000188	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—stomach cancer	7.26e-06	0.000187	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—stomach cancer	7.25e-06	0.000187	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—stomach cancer	7.18e-06	0.000185	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD44—stomach cancer	7.13e-06	0.000184	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.09e-06	0.000183	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—stomach cancer	7.08e-06	0.000183	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SREBF2—stomach cancer	7.06e-06	0.000182	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—RORA—stomach cancer	6.98e-06	0.00018	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPP2R1A—stomach cancer	6.92e-06	0.000179	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—stomach cancer	6.84e-06	0.000176	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ERCC2—stomach cancer	6.81e-06	0.000176	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—stomach cancer	6.79e-06	0.000175	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—stomach cancer	6.7e-06	0.000173	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDOB—stomach cancer	6.54e-06	0.000169	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—stomach cancer	6.54e-06	0.000169	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—stomach cancer	6.47e-06	0.000167	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK3—stomach cancer	6.47e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—stomach cancer	6.46e-06	0.000167	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—stomach cancer	6.4e-06	0.000165	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TYMS—stomach cancer	6.31e-06	0.000163	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—stomach cancer	6.24e-06	0.000161	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPP2R1A—stomach cancer	6.22e-06	0.00016	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK3—stomach cancer	6.19e-06	0.000159	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—stomach cancer	6.18e-06	0.000159	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK1—stomach cancer	6.15e-06	0.000159	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—stomach cancer	6.1e-06	0.000157	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALOX5—stomach cancer	6.08e-06	0.000157	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPP2R1A—stomach cancer	6.07e-06	0.000156	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—stomach cancer	6.02e-06	0.000155	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—stomach cancer	6.01e-06	0.000155	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—DPYD—stomach cancer	5.98e-06	0.000154	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—stomach cancer	5.95e-06	0.000153	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAV1—stomach cancer	5.91e-06	0.000152	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA1—stomach cancer	5.89e-06	0.000152	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK1—stomach cancer	5.89e-06	0.000152	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EGFR—stomach cancer	5.88e-06	0.000152	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—stomach cancer	5.87e-06	0.000151	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ERCC2—stomach cancer	5.87e-06	0.000151	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—stomach cancer	5.81e-06	0.00015	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TYMS—stomach cancer	5.67e-06	0.000146	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—stomach cancer	5.65e-06	0.000146	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—stomach cancer	5.6e-06	0.000144	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—stomach cancer	5.56e-06	0.000143	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TYMS—stomach cancer	5.53e-06	0.000143	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—stomach cancer	5.52e-06	0.000142	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—stomach cancer	5.47e-06	0.000141	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—stomach cancer	5.34e-06	0.000138	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—stomach cancer	5.29e-06	0.000136	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ERCC2—stomach cancer	5.27e-06	0.000136	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.23e-06	0.000135	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—stomach cancer	5.19e-06	0.000134	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—stomach cancer	5.16e-06	0.000133	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ERCC2—stomach cancer	5.14e-06	0.000133	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—stomach cancer	5.11e-06	0.000132	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAV1—stomach cancer	5.09e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.09e-06	0.000131	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA1—stomach cancer	5.08e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ENO1—stomach cancer	4.96e-06	0.000128	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—stomach cancer	4.95e-06	0.000128	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—stomach cancer	4.94e-06	0.000127	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HRAS—stomach cancer	4.94e-06	0.000127	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.86e-06	0.000125	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—stomach cancer	4.83e-06	0.000125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HRAS—stomach cancer	4.72e-06	0.000122	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—stomach cancer	4.67e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAV1—stomach cancer	4.57e-06	0.000118	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA1—stomach cancer	4.56e-06	0.000117	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—stomach cancer	4.52e-06	0.000117	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—stomach cancer	4.47e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—stomach cancer	4.47e-06	0.000115	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAV1—stomach cancer	4.46e-06	0.000115	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA1—stomach cancer	4.45e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD44—stomach cancer	4.4e-06	0.000113	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.36e-06	0.000112	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—stomach cancer	4.09e-06	0.000105	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—stomach cancer	4.01e-06	0.000104	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—stomach cancer	3.92e-06	0.000101	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—stomach cancer	3.85e-06	9.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.74e-06	9.64e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—stomach cancer	3.67e-06	9.45e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—stomach cancer	3.62e-06	9.32e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—stomach cancer	3.61e-06	9.31e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—stomach cancer	3.52e-06	9.08e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—stomach cancer	3.52e-06	9.07e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—stomach cancer	3.48e-06	8.96e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—stomach cancer	3.45e-06	8.9e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TYMS—stomach cancer	3.41e-06	8.79e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—stomach cancer	3.37e-06	8.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—stomach cancer	3.37e-06	8.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ERCC2—stomach cancer	3.17e-06	8.17e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—stomach cancer	3.16e-06	8.14e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—stomach cancer	3.08e-06	7.95e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—stomach cancer	2.98e-06	7.68e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAV1—stomach cancer	2.75e-06	7.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA1—stomach cancer	2.74e-06	7.06e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.51e-06	6.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—stomach cancer	2.41e-06	6.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—stomach cancer	2.17e-06	5.6e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—stomach cancer	2.16e-06	5.58e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—stomach cancer	2.08e-06	5.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.94e-06	5.01e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—stomach cancer	1.9e-06	4.9e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—stomach cancer	1.9e-06	4.89e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.17e-06	3.01e-05	CbGpPWpGaD
